Andere Sprachen Eledon Pharmaceuticals, Inc.

Aktien

A2QL00

US28617K1016

ELDN

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 17.04.2024			% 5 Tage	% 1. Jan.
1.57 ^USD	-1.88%		-6.55%	-12.78%

28.03.	Eledon Pharmaceuticals, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
25.03.	Eledon Pharmaceuticals meldet 12. Teilnehmer in Tegoprubart-Studie; Aktien steigen nachbörslich an	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Eledon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results	28.03.
Eledon Pharmaceuticals Says 12th Participant Enrolled in Tegoprubart Trial; Shares Rise After Hours	25.03.
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection	25.03.
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection	25.03.
Sector Update: Health Care Stocks Higher in Late Afternoon Trading	21.03.
Sector Update: Health Care	21.03.
Eledon Pharmaceuticals Says Tegoprubart Used in Kidney Transplant From Pig to Human	21.03.
USA-Un homme greffé avec le rein d'un porc, une première mondiale	21.03.
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human	21.03.
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human	21.03.
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	14.02.
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	14.02.
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook	04.01.
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05.12.
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05.12.
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference	29.11.
Eledon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results	09.11.
Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference	08.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Eledon Pharmaceuticals, Inc.

Aktien

A2QL00

US28617K1016

ELDN

Andere Sprachen

Filter